Join the 200th Anniversary Celebration

Original Article

Severe Anemia in Malawian Children

Job C.J. Calis, M.D., Kamija S. Phiri, M.D., E. Brian Faragher, Ph.D., Bernard J. Brabin, F.R.C.P.C.H., Imelda Bates, M.D., Luis E. Cuevas, M.D., Rob J. de Haan, Ph.D., Ajib I. Phiri, M.D., Pelani Malange, M.Sc., Mirriam Khoka, B.Sc., Paul J.M. Hulshof, M.Sc., Lisette van Lieshout, Ph.D., Marcel G.H.M. Beld, Ph.D., Yik Y. Teo, Ph.D., Kirk A. Rockett, Ph.D., Anna Richardson, B.Sc., Dominic P. Kwiatkowski, F.R.C.P., Malcolm E. Molyneux, F.R.C.P., and Michaël Boele van Hensbroek, M.D.

N Engl J Med 2008; 358:888-899February 28, 2008

Abstract

Background

Severe anemia is a major cause of sickness and death in African children, yet the causes of anemia in this population have been inadequately studied.

Methods

We conducted a case–control study of 381 preschool children with severe anemia (hemoglobin concentration, <5.0 g per deciliter) and 757 preschool children without severe anemia in urban and rural settings in Malawi. Causal factors previously associated with severe anemia were studied. The data were examined by multivariate analysis and structural equation modeling.

Results

Bacteremia (adjusted odds ratio, 5.3; 95% confidence interval [CI], 2.6 to 10.9), malaria (adjusted odds ratio, 2.3; 95% CI, 1.6 to 3.3), hookworm (adjusted odds ratio, 4.8; 95% CI, 2.0 to 11.8), human immunodeficiency virus infection (adjusted odds ratio, 2.0; 95% CI, 1.0 to 3.8), the G6PD −202/−376 genetic disorder (adjusted odds ratio, 2.4; 95% CI, 1.3 to 4.4), vitamin A deficiency (adjusted odds ratio, 2.8; 95% CI, 1.3 to 5.8), and vitamin B12 deficiency (adjusted odds ratio, 2.2; 95% CI, 1.4 to 3.6) were associated with severe anemia. Folate deficiency, sickle cell disease, and laboratory signs of an abnormal inflammatory response were uncommon. Iron deficiency was not prevalent in case patients (adjusted odds ratio, 0.37; 95% CI, 0.22 to 0.60) and was negatively associated with bacteremia. Malaria was associated with severe anemia in the urban site (with seasonal transmission) but not in the rural site (where malaria was holoendemic). Seventy-six percent of hookworm infections were found in children under 2 years of age.

Conclusions

There are multiple causes of severe anemia in Malawian preschool children, but folate and iron deficiencies are not prominent among them. Even in the presence of malaria parasites, additional or alternative causes of severe anemia should be considered.

Media in This Article

Figure 1Adjusted Odds Ratios and 95% Confidence Intervals for Factors Associated with Severe Anemia, According to Study Group and Recruitment Site.
Figure 2Structural Equation Model for Severe Anemia, Iron Deficiency, and Malaria.
Article

Severe anemia (hemoglobin concentration less than 5.0 g per deciliter) is a major cause of sickness and death among children in sub-Saharan Africa.1-4 In various settings, 12 to 29% of hospitalized children are severely anemic,1-4 and the in-hospital case fatality rate in these children is 8 to 17%.1,3,4 Little is known about the causes of severe anemia in African children. Most studies have been confined to the anemia associated with malaria5 or with other individual factors.1,2,6 As a result, the treatment guidelines advocated by the World Health Organization (WHO) deal specifically with malaria, folate deficiency, and iron deficiency, which are widely held to be the most common causes of severe anemia in African children.7 To improve our understanding of severe anemia, we conducted a case–control study in Malawi to assess the causative factors in Malawian children with severe anemia.

Methods

Study Sites

We conducted the study in Malawi at Chikwawa District Hospital in a rural area where malaria infections occur throughout the year (approximately 170 infectious bites per person per year) and at Queen Elizabeth Central Hospital, a referral hospital in urban Blantyre, where malaria is seasonal, largely coinciding with the rainy season (approximately 1 infectious bite per person per year) (Mzilahowa T: personal communication). Predefined catchment areas were used; the urban area was confined to the city limits.

Study Design

Between July 2002 and July 2004, a consecutive sample of children (382 case patients) who presented at the outpatient department during working hours with a primary diagnosis of severe anemia (defined as a hemoglobin concentration of <5.0 g per deciliter) were recruited into a prospective case–control study. Additional inclusion criteria were an age between 6 and 60 months and no blood transfusion within the previous 4 weeks.

For each case patient, a community control patient and a hospital control patient were enrolled. Community control patients were recruited from apparently healthy residents living within 100 to 1000 m of the case patient; hospital control patients were recruited by selecting the first child presenting at the outpatient department at the same time on the next working day after presentation of the case patient. Community and hospital control patients were eligible for recruitment if their hemoglobin level was at least 5.0 g per deciliter and they were between 6 and 60 months of age; no other matching was applied. Written informed consent was obtained from a parent or a guardian of each child in all three study groups. The study was approved by the ethics committees of the College of Medicine, Malawi, and the Liverpool School of Tropical Medicine, United Kingdom.

Clinical Assessment and Management

On enrollment, a clinical research form, including a medical and dietary history, sociodemographic data, and physical examination, was completed, and samples of blood, urine, and stool were collected. In case patients, if the clinical condition permitted it, a bone marrow aspirate was obtained under local anesthesia. Children requiring admission were treated in a study ward. All conditions were managed according to standard protocols.

Anthropometric Measurements

Nutritional z scores were calculated according to the WHO growth reference curves8 with the use of Epi Info 2000. Weight-for-height, height-for-age, and weight-for-age z scores of less than −2 were considered to indicate wasting, stunting, and underweight, respectively; z scores of less than −3 were considered to indicate severe wasting, severe stunting, or severe underweight.

Laboratory Methods

Laboratory tests (hematologic, bacteriologic, and parasitologic) were performed within 24 hours after collection, and aliquots were stored at −80°C for later analysis. The laboratory staff were unaware of the children's study groups.

Hematologic Studies

Hemoglobin concentration was measured on site with a HemoCue system. A complete blood count, including reticulocytes, was performed by a Coulter counter. In case patients, bone marrow slides were stained with Hematognost Fe (Merck) and graded for iron content9; these results were used to validate peripheral blood markers of iron deficiency. The ratio of soluble transferrin receptor to log ferritin (TfR-F index)10 best predicted bone marrow iron status, irrespective of the presence of infection; a TfR-F index greater than 5.6 was used to define iron deficiency with a sensitivity of 70% and a specificity of 75% (unpublished data).

Chemical Studies

Plasma levels of C-reactive protein, haptoglobin, transferrin, iron, ferritin, folate, and vitamin B12 were analyzed on Modular P800 and Modular Analytics E170 systems (Roche). Inflammatory cytokine profiles were measured by Cytometric Bead Array on a FACSCalibur flow cytometer (Becton Dickinson). Serum vitamin A (retinol) and soluble transferrin receptor were measured by high-performance liquid chromatography11 and enzyme-linked immunosorbent assay, respectively.

Parasitologic Studies

The number of Plasmodium falciparum asexual parasites per 200 white cells was counted and expressed as the number per microliter of blood. Malaria slides were read by two independent readers, with a third being used if the results differed by more than 25%. Malaria was defined by the presence of P. falciparum asexual parasites. Recent or current malaria was defined by the presence of P. falciparum asexual parasites in erythrocytes or malaria pigment in monocytes or macrophages.12 Hyperparasitemia was defined as more than 100,000 parasites per microliter.2 Stool samples were examined for helminths by the Kato–Katz method.13 Heavy hookworm infection was defined by the presence of more than 1000 ova per gram of feces. A polymerase-chain-reaction (PCR) test was used to confirm the microscopical results and define the species (Ancylostoma duodenale or Necator americanus).14 Urine specimens were examined for Schistosoma haematobium by a semiquantitative concentration method.15

Bacteriologic Studies

A bone marrow or venous blood sample (1 to 2 ml) was inoculated into BACTEC Myco/F-Lytic culture vials and incubated in a BACTEC 9050 automated culture system (Becton Dickinson) for 56 days. Subculturing, susceptibility testing, and isolate identification were performed by standard techniques.16 Cultures were checked for mycobacteria with the use of Ziehl–Neelsen staining of smears. Mixed growths or growths of micrococci, bacillus species, or coagulase-negative staphylococci were considered contaminants.

Virologic Studies

Whole-blood isolates17 were assessed for Epstein–Barr virus and cytomegalovirus infection by semiquantitative PCR18 and for parvovirus by real-time PCR.19 Infections were considered clinically important if the number of viral copies exceeded 1000 per milliliter of blood. Testing for human immunodeficiency virus (HIV) was performed by two rapid tests (Determine, Abbott Laboratories; and Uni-Gold, Trinity Biotech). Discordant or positive rapid-test results in children less than 18 months of age were resolved by PCR.20

Genetic Studies

DNA was extracted with a Nucleon extraction kit (Amersham Biosciences) and genotyped by primer-extension mass spectrometry with the use of MassARRAY (Sequenom).21 The presence of sickle cell disease (homozygosity for hemoglobin S) and single-nucleotide polymorphisms in the promoter regions of the genes encoding interleukin-10 (IL10) (–1117, −3585, and +4949)21 and tumor necrosis factor (TNF) (−238, −308, and −1031)22 was determined. The term G6PD −202/−376 is used to denote boys who are hemizygous and girls who are homozygous for both the G6PD202A and the G6PD376G alleles, a condition that is strongly predictive of glucose-6-phosphate dehydrogenase deficiency.23 The Hardy–Weinberg equilibrium was applied (cutoff, P<0.001), and there was no significant population stratification. We chose the allele frequency, dominant model, or haplotype that was most strongly associated with severe anemia.

Statistical Analysis

The prevalence rates of each factor were compared individually across the three groups with the use of Fisher's exact test and the chi-square test. The combined association of characteristics related to the risk of severe anemia (P≤0.10, unless the characteristics were uncommon [<5%]) was examined by an unconditional multivariate logistic-regression model corrected for potential confounding factors (age, sex, recent use [i.e., within the previous 8 weeks] of antimalarial or hematinic agents, and a history of transfusions [i.e., before the previous 4 weeks]). Missing observations were included in the analysis by creating missing-value categories. Alternative definitions for malaria, hookworm, and nutritional deficiencies and status were tested. Attributable-risk percentages were calculated with the use of adjusted odds ratios.24 The primary analysis compared all case patients with the two control groups combined. To explore the possibility that different patient characteristics were important in the two study locations, secondary analyses were performed with stratification according to location and with the community and hospital control groups separated. More complex associations and alternative strategies for handling missing data (e.g., maximum-likelihood imputation) were explored by structural equation modeling.25 All reported P values are two-sided. The data were analyzed with the use of Stata (version 9), SPSS (version 12), and Amos (version 6.0) software.

Results

We enrolled 1141 children over a 2-year period. Five protocol violations occurred: two hospital control children had severe anemia and were redesignated as case patients, one case patient with a hemoglobin concentration of more than 5.0 g per deciliter was excluded, and two control patients under 6 months of age were excluded. Table 1Table 1Characteristics of the Study Groups. summarizes the characteristics of the 1138 children included in the analysis. Hemoglobin levels differed significantly between the case patients and each of the two control groups but were similar in the two control groups. Splenomegaly (in which >1 cm of the spleen was palpable) and severe splenomegaly (in which ≥8 cm was palpable) were more common in case patients (P<0.001 and P=0.03, respectively). Severe splenomegaly, which was present in 11 case patients (3.0%), was not associated with thrombocytopenia or leukopenia. Jaundice was more common in case patients (5.0%) but was not associated with sickle cell disease (P=1.00), G6PD −202/−376 (P=0.70), or splenomegaly (P=0.30). Twenty-four case patients (6.3%) died after admission to the hospital, nine (37.5%) before receiving a transfusion. We obtained samples of peripheral blood from 1105 subjects (97.1%), stool from 1024 subjects (90.0%), urine from 1042 subjects (91.6%), and bone marrow from 348 case patients (91.3%). Table 2Table 2Distribution of Possible Etiologic and Confounding Factors among Study Groups According to Recruitment Sites. lists the features we investigated in the three groups and gives the P values for differences among the groups. Factors significantly associated with severe anemia were further explored in a multivariate and structural equation model (Figure 1Figure 1Adjusted Odds Ratios and 95% Confidence Intervals for Factors Associated with Severe Anemia, According to Study Group and Recruitment Site. and Figure 2Figure 2Structural Equation Model for Severe Anemia, Iron Deficiency, and Malaria.).

Malaria

P. falciparum was identified in 226 case patients (59.5%) and 321 control patients (42.8%) and was the predominant malarial species overall (97.5%). P. malariae was found in 1.6% and a mixed infection in 0.9% of the study patients. The attributable risk of severe anemia associated with P. falciparum was 33.5% overall and 47.3% in the urban setting. In the rural setting, a significant association between malaria and severe anemia was found only in the subgroup of patients who had hyperparasitemia (9.7%) (adjusted odds ratio for case patients vs. community controls, 7.1; 95% confidence interval [CI], 1.4 to 34.6).

HIV

HIV infection was found in 86 children (12.6% of case patients and 6.0% of controls). The attributable risk of severe anemia associated with HIV was 6.2% overall and 15.4% in the urban setting. Among severely anemic children, significantly more HIV-infected than HIV-uninfected children had Epstein–Barr virus infection (15 of 30 [50.0%] vs. 69 of 226 [30.5%], P=0.03) or bacteremia (11 of 42 [26.2%] vs. 38 of 300 [12.7%], P=0.02), whereas significantly fewer HIV-infected than HIV-uninfected children had hyperparasitemia (2 of 44 [4.5%] vs. 42 of 312 [13.5%], P=0.09) or vitamin B12 deficiency (5 of 39 [12.8%] vs. 85 of 254 [33.5%], P=0.009).

Bacteremia

Fifty-four case patients (15.0%) and 14 controls (4.0%) had bacteremia. The attributable risk of severe anemia associated with bacteremia was 12.2%. The most common pathogen was nontyphoid salmonella, which was present in 38 of the case patients (70.4%) and 11 of the controls (78.6%) who had bacteremia (P=0.54). No mycobacteria were isolated from any of the specimens. Fever was absent in 36.8% of children with bacteremia. Among case patients, bacteremia was less common in children with malaria than in those without malaria (21 of 208 [10.1%] vs. 32 of 150 [21.3%], P=0.003). Among control patients, bacteremia was also less common in children with malaria than in those without (3 of 146 [2.1%] vs. 11 of 207 [5.3%], P=0.12).

Nutrition

Fifty-two case patients (15.8%) and 43 control patients (6.2%) had wasting; the attributable risk of severe anemia associated with wasting was 6.2%. Severely anemic children were commonly stunted (53.2%) or underweight (49.2%), but for both conditions the unadjusted and adjusted odds ratios were similar to those for wasting (data not shown). Severe wasting occurred in 3.7% of severely anemic children.

Vitamin B12 deficiency was found in 95 case patients (30.4%) and 94 controls (15.6%) and was severe (<13.6 ng per deciliter [100 pmol per liter]) in 11.2% of case patients and 2.8% of controls (adjusted odds ratio, 4.3; 95% CI, 1.9 to 9.9). Macrocytosis was more common in children with vitamin B12 deficiency than in children with normal vitamin B12 levels (P=0.02), although the sensitivity for vitamin B12 deficiency was low (17.5%). Severely anemic children with vitamin B12 deficiency ate fewer meals with meat than those not deficient (1.9 vs. 2.7 per month, P=0.02). Folate deficiency was not found in any child enrolled in the study. Vitamin B12 and folate levels were inversely correlated with each other among severely anemic children (Pearson correlation coefficient, −0.22; P=0.01).

Vitamin A deficiency was found in 92.3% of case patients and 65.6% of controls and was considered severe (less than 10 μg per deciliter) in 32.8% of case patients and 14.9% of controls (adjusted odds ratio, 1.6; 95% CI, 0.91 to 2.76). Vitamin A deficiency was associated with malaria and bacteremia in the structural equation model. Iron deficiency was found in 46.6% of case patients and 69.4% of controls. Further exploration indicated this finding was not affected by the definition used (Table 3Table 3Prevalence of Iron Deficiency in Relation to the Development of Severe Anemia, According to Several Peripheral Blood Markers.). In the structural equation model, iron deficiency was found to be inversely associated with bacteremia (P=0.006).

Hookworm

Hookworm was the most common helminth infection. Thirty-one (75.6%) of the hookworm infections occurred in children less than 2 years old. The attributable risk of severe anemia associated with hookworm in the rural site, where 95.1% of infections were seen, was 15.9%. In this site, 10.4% of case patients and 0.6% of controls had heavy infections (adjusted odds ratio, 9.4; 95% CI, 2.0 to 44.8). PCR was performed on 36 of 41 positive samples (87.8%). A. duodenale was found in 80.6% of these samples, N. americanus in 8.3%, and a mixed infection in 11.1%. Hookworm infection was associated with iron deficiency (P=0.003) (Figure 2).

Sickle Cell and G6PD Variants

No association was found between severe anemia and sickle cell disease or between severe anemia and sickle cell trait (P=0.45 and P=0.20, respectively). Jaundice was uncommon in severely anemic children with sickle cell disease (0%) or G6PD −202/−376 (2.3%). Haptoglobin levels were commonly decreased (<0.30 g per liter) in case patients with G6PD −202/−376 (78.4%). Boys accounted for 68.2% of children with G6PD −202/−376, but after stratification, G6PD −202/−376 remained significantly associated with severe anemia in girls (adjusted odds ratio, 4.1; 95% CI, 1.2 to 13.3) and boys (adjusted odds ratio, 2.2; 95% CI, 1.1 to 4.7).

Discussion

In many African hospitals, severe anemia is a leading reason for admission and a major contributor to death. The cause of the anemia has not been comprehensively investigated, but we found several important associations in this study.

Malaria is commonly considered to be a principal cause of severe anemia in Africa.7 In this study, P. falciparum parasitemia was strongly associated with severe anemia in the area with seasonal transmission but not in the area with holoendemic transmission. However, the cumulative effect of malaria on an individual person is difficult to assess in holoendemic settings where children are repeatedly infected. Our findings therefore do not exclude malaria as a predisposing cause of severe anemia in the rural area but indicate that additional or alternative diagnoses should be considered in severely anemic children who receive a diagnosis of malaria infection. In the structural equation model, malaria and bacteremia were identified as variables that modify the association between vitamin A deficiency and severe anemia. This is in line with earlier observations that vitamin A deficiency is associated with an increased susceptibility to infection.28 A vitamin A supplementation trial showed a reduction in the incidence of malaria,29 although this and another study failed to show that vitamin A supplementation reduced the incidence of severe anemia.29,30

We found an inverse association between iron deficiency and severe anemia. The structural equation model partly explains this finding by indicating that iron deficiency was inversely associated with bacteremia. This finding supports the hypothesis that iron deficiency protects against infection by creating an unfavorable environment for bacterial growth.31,32 It is also in agreement with observations of increased morbidity and mortality during iron-supplementation studies in areas where bacterial infections are common.32,33 Although iron supplementation may have a role in preventing anemia,33 supplementation after severe anemia of malaria had no hematologic benefits and resulted in increased morbidity in Tanzanian children.34

In rural children with severe anemia, we found an increased prevalence and intensity of hookworm infections, with A. duodenale being the predominant species. Three quarters of the hookworm-infected children were less than 2 years of age. This age group would have remained untreated according to the current guidelines.7 Although hookworm is usually more frequent among older children, younger children might be more vulnerable to severe hematologic complications, especially in the presence of heavy infections with A. duodenale.35

Bacteremia, most commonly due to nontyphoid salmonella, was strongly associated with severe anemia. This association has been described previously16,36,37 but is not reflected in current management guidelines for severe anemia in children.7 In the structural equation model, bacteremia was also identified as a mediating variable of the effect of HIV on severe anemia. Although bacteremia might not necessarily be a cause of severe anemia, its high prevalence may justify antibiotic treatment in the standard management of severe anemia in settings where HIV is prevalent and blood-culture facilities are not available.

Although folate supplementation is recommended by the WHO, folate deficiency was not found in our study groups. We may have underestimated its prevalence, because folate deficiency can be masked by vitamin B12 deficiency,38 and we measured plasma concentrations of folate rather than erythrocyte concentrations. However, our findings concur with previous reports39 and observations that folate supplementation in anemic children with malaria failed to raise hemoglobin concentrations.40 Unlike folate, vitamin B12 is not recommended in the management of severe anemia. In our population, vitamin B12 deficiency was found in 30.4% of case patients and was associated with severe anemia. This is in agreement with findings among adults in this region41,42 and may be explained by the lack of animal products in the diet of Malawian children.

G6PD −202/−376 was found in 13.8% of case patients and was associated with severe anemia, whereas sickle cell disease was uncommon in our study. The roles of these mutations may be different in West and Central Africa. Possible associations of interleukin-10 and tumor necrosis factor α with severe anemia of malaria have been described,22,43 but in our study an imbalance in circulating plasma levels of interleukin-10 and tumor necrosis factor α was uncommon.

We found that several independent yet overlapping conditions are associated with severe anemia in Malawian children: bacteremia, malaria, hookworm, HIV infection, G6PD −202/−376, vitamin A deficiency, and vitamin B12 deficiency. Our findings indicate that even in the presence of malaria parasites, additional or alternative diagnoses should be considered. Current treatment recommendations that promote iron and folate supplements and ignore bacteremia, vitamin B12 deficiency, and, in young children, hookworm infections appear to be of limited applicability in our setting. Our findings, if confirmed in different settings, will contribute to the assessment of new therapeutic and preventive strategies for Africa.

Supported by a grant (064722) from the Wellcome Trust and by independent grants from the Nutricia Research Foundation and the Ter Meulen Fund of the Royal Netherlands Academy of Arts and Sciences.

No potential conflict of interest relevant to this article was reported.

We thank the parents and guardians of the children admitted to the study; the Severe Anemia (SevAna) study team; and the staffs of the Queen Elizabeth Central Hospital, the Chikwawa District Hospital, and the Wellcome Trust Research Laboratories, especially S.M. Graham, E.M. Molyneux, T.N. Williams, M. Cornelissen, H. van den Berg, R.J.W.M. Vet, Z. Ayde, A. van Breda, J.J. Verweij, B.J.E. van Geenen, M.A. Sanjoaquin, R.J. Kraaijenhagen, F.A. Wijnberg, and W.J. van Lüling, for their contribution to the study.

Source Information

From the Malawi–Liverpool–Wellcome Trust Clinical Research Programme, College of Medicine (J.C.J.C., K.S.P., A.I.P., P.M., M.K., M.E.M., M.B.H.) and the College of Medicine (J.C.J.C., K.S.P., A.I.P., M.E.M., M.B.H.), Blantyre, Malawi; Emma Children's Hospital, the Global Child Health Group (J.C.J.C., B.J.B., M.B.H.), the Department of Clinical Epidemiology and Biostatistics (R.J.H.), and the Department of Medical Microbiology, Laboratory of Clinical Virology (M.G.H.M.B.) — all at the Academic Medical Center, Amsterdam; the Liverpool School of Tropical Medicine (E.B.F., I.B., M.E.M.) and the Child and Reproductive Health Group, Liverpool School of Tropical Medicine (B.J.B., L.E.C., M.B.H.), Liverpool, United Kingdom; the Division of Human Nutrition, Wageningen University, Wageningen, the Netherlands (P.J.M.H.); the Department of Parasitology, Leiden University Medical Center, Leiden, the Netherlands (L.L.); and the Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom (Y.Y.T., K.A.R., A.R., D.P.K.).

Address reprint requests to Dr. Calis at Emma Children's Hospital, Academic Medical Center, the Global Child Health Group, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands, or at .

References

References

  1. 1

    English M, Ahmed M, Ngando C, Berkley J, Ross A. Blood transfusion for severe anaemia in children in a Kenyan hospital. Lancet 2002;359:494-495
    CrossRef | Web of Science | Medline

  2. 2

    Koram KA, Owusu-Agyei S, Utz G, et al. Severe anemia in young children after high and low malaria transmission seasons in the Kassena-Nankana district of northern Ghana. Am J Trop Med Hyg 2000;62:670-674
    Web of Science | Medline

  3. 3

    Lackritz EM, Campbell CC, Ruebush TK II, et al. Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet 1992;340:524-528
    CrossRef | Web of Science | Medline

  4. 4

    Newton CR, Warn PA, Winstanley PA, et al. Severe anaemia in children living in a malaria endemic area of Kenya. Trop Med Int Health 1997;2:165-178
    CrossRef | Web of Science | Medline

  5. 5

    Biemba G, Dolmans D, Thuma PE, Weiss G, Gordeuk VR. Severe anaemia in Zambian children with Plasmodium falciparum malaria. Trop Med Int Health 2000;5:9-16
    CrossRef | Web of Science | Medline

  6. 6

    Dicko A, Klion AD, Thera MA, et al. The etiology of severe anemia in a village and a periurban area in Mali. Blood 2004;104:1198-1200
    CrossRef | Web of Science | Medline

  7. 7

    Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia. Geneva: World Health Organization, 1998. (Accessed February 4, 2008, at http://www.who.int/nutrition/publications/anaemia_iron_pub/en/index.html.)

  8. 8

    Dibley MJ, Goldsby JB, Staehling NW, Trowbridge FL. Development of normalized curves for the international growth reference: historical and technical considerations. Am J Clin Nutr 1987;46:736-748
    Web of Science | Medline

  9. 9

    Gale E, Torrence J, Bothwell T. The quantitative estimation of total iron stores in human bone marrow. J Clin Invest 1963;42:1076-1082
    CrossRef | Web of Science | Medline

  10. 10

    Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89:1052-1057
    Web of Science | Medline

  11. 11

    Bieri JG, Tolliver TJ, Catignani GL. Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. Am J Clin Nutr 1979;32:2143-2149
    Web of Science | Medline

  12. 12

    Sullivan AD, Ittarat I, Meshnick SR. Patterns of haemozoin accumulation in tissue. Parasitology 1996;112:285-294
    CrossRef | Web of Science | Medline

  13. 13

    Katz N, Coelho PM, Pellegrino J. Evaluation of Kato's quantitative method through the recovery of Schistosoma mansoni eggs added to human feces. J Parasitol 1970;56:1032-1033
    CrossRef | Web of Science | Medline

  14. 14

    de Gruijter JM, van Lieshout L, Gasser RB, et al. Polymerase chain reaction-based differential diagnosis of Ancylostoma duodenale and Necator americanus infections in humans in northern Ghana. Trop Med Int Health 2005;10:574-580
    CrossRef | Web of Science | Medline

  15. 15

    Shaker ZA, Hassan SI, el-Attar GM, et al. Use of Kato and nucleopore techniques for qualitative diagnosis of schistosomiasis. J Egypt Soc Parasitol 1994;24:656-662
    Medline

  16. 16

    Graham SM, Walsh AL, Molyneux EM, Phiri AJ, Molyneux ME. Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. Trans R Soc Trop Med Hyg 2000;94:310-314
    CrossRef | Web of Science | Medline

  17. 17

    Boom R, Sol C, Beld M, Weel J, Goudsmit J, Wertheim-van Dillen P. Improved silica-guanidiniumthiocyanate DNA isolation procedure based on selective binding of bovine alpha-casein to silica particles. J Clin Microbiol 1999;37:615-619
    Web of Science | Medline

  18. 18

    Boom R, Sol C, Weel J, Gerrits Y, de Boer M, Wertheim-van Dillen P. A highly sensitive assay for detection and quantitation of human cytomegalovirus DNA in serum and plasma by PCR and electrochemiluminescence. J Clin Microbiol 1999;37:1489-1497
    Web of Science | Medline

  19. 19

    Koppelman MH, Cuypers HT, Emrich T, Zaaijer HL. Quantitative real-time detection of parvovirus B19 DNA in plasma. Transfusion 2004;44:97-103
    CrossRef | Web of Science | Medline

  20. 20

    Molyneux EM, Tembo M, Kayira K, et al. The effect of HIV infection on paediatric bacterial meningitis in Blantyre, Malawi. Arch Dis Child 2003;88:1112-1118[Erratum, Arch Dis Child 2004;89:395.]
    CrossRef | Web of Science | Medline

  21. 21

    Wilson JN, Rockett K, Jallow M, et al. Analysis of IL10 haplotypic associations with severe malaria. Genes Immun 2005;6:462-466
    CrossRef | Web of Science | Medline

  22. 22

    May J, Lell B, Luty AJ, Meyer CG, Kremsner PG. Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications. J Infect Dis 2000;182:1570-1573
    CrossRef | Web of Science | Medline

  23. 23

    Hirono A, Beutler E. Molecular cloning and nucleotide sequence of cDNA for human glucose-6-phosphate dehydrogenase variant A(−). Proc Natl Acad Sci U S A 1988;85:3951-3954
    CrossRef | Web of Science | Medline

  24. 24

    Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985;122:904-914
    Web of Science | Medline

  25. 25

    Arbuckle JL. Amos 6.0 user's guide. Chicago: SPSS, 2007.

  26. 26

    van den Broek NR, Letsky EA, White SA, Shenkin A. Iron status in pregnant women: which measurements are valid? Br J Haematol 1998;103:817-824
    CrossRef | Web of Science | Medline

  27. 27

    Iron deficiency anaemia: assessment, prevention and control: a guide for programme managers. Geneva: World Health Organization, 2001. (Accessed February 4, 2008, at http://www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf.)

  28. 28

    Sommer A, Tarwotjo I, Hussaini G, Susanto D. Increased mortality in children with mild vitamin A deficiency. Lancet 1983;2:585-588
    CrossRef | Web of Science | Medline

  29. 29

    Shankar AH, Genton B, Semba RD, et al. Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: a randomised trial. Lancet 1999;354:203-209
    CrossRef | Web of Science | Medline

  30. 30

    Villamor E, Mbise R, Spiegelman D, Ndossi G, Fawzi WW. Vitamin A supplementation and other predictors of anemia among children from Dar Es Salaam, Tanzania. Am J Trop Med Hyg 2000;62:590-597
    Web of Science | Medline

  31. 31

    Chlosta S, Fishman DS, Harrington L, et al. The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect Immun 2006;74:3065-3067
    CrossRef | Web of Science | Medline

  32. 32

    Murray MJ, Murray AB, Murray MB, Murray CJ. The adverse effect of iron repletion on the course of certain infections. BMJ 1978;2:1113-1115
    CrossRef | Web of Science | Medline

  33. 33

    Sazawal S, Black RE, Ramsan M, et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006;367:133-143[Erratum, Lancet 2006;367:302.]
    CrossRef | Web of Science | Medline

  34. 34

    van den Hombergh J, Dalderop E, Smit Y. Does iron therapy benefit children with severe malaria-associated anaemia? A clinical trial with 12 weeks supplementation of oral iron in young children from the Turiani Division, Tanzania. J Trop Pediatr 1996;42:220-227
    CrossRef | Web of Science | Medline

  35. 35

    Albonico M, Stoltzfus RJ, Savioli L, et al. Epidemiological evidence for a differential effect of hookworm species, Ancylostoma duodenale or Necator americanus, on iron status of children. Int J Epidemiol 1998;27:530-537
    CrossRef | Web of Science | Medline

  36. 36

    Brent AJ, Oundo JO, Mwangi I, Ochola L, Lowe B, Berkley JA. Salmonella bacteremia in Kenyan children. Pediatr Infect Dis J 2006;25:230-236
    CrossRef | Web of Science | Medline

  37. 37

    Bronzan RN, Taylor TE, Mwenechanya J, et al. Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome. J Infect Dis 2007;195:895-904
    CrossRef | Web of Science | Medline

  38. 38

    Dierkes J, Domrose U, Ambrosch A, et al. Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease. Metabolism 1999;48:631-635
    CrossRef | Web of Science | Medline

  39. 39

    Abdalla SH. Iron and folate status in Gambian children with malaria. Ann Trop Paediatr 1990;10:265-272
    Web of Science | Medline

  40. 40

    Van Hensbroek MB, Morris-Jones S, Meisner S, et al. Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. Trans R Soc Trop Med Hyg 1995;89:672-676
    CrossRef | Web of Science | Medline

  41. 41

    Savage DG, Allen RH, Gangaidzo IT, et al. Pancytopenia in Zimbabwe. Am J Med Sci 1999;317:22-32
    CrossRef | Web of Science | Medline

  42. 42

    van den Broek NR, Letsky EA. Etiology of anemia in pregnancy in south Malawi. Am J Clin Nutr 2000;72:Suppl:247S-256S
    Web of Science | Medline

  43. 43

    Kurtzhals JA, Adabayeri V, Goka BQ, et al. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 1998;351:1768-1772[Erratum, Lancet 1998;352:242, 1999;353:848.]
    CrossRef | Web of Science | Medline

Citing Articles (29)

Citing Articles

  1. 1

    Kamija Phiri, Michael Esan, Michael Boele van Hensbroek, Carole Khairallah, Brian Faragher, Feiko O ter Kuile. (2011) Intermittent preventive therapy for malaria with monthly artemether–lumefantrine for the post-discharge management of severe anaemia in children aged 4–59 months in southern Malawi: a multicentre, randomised, placebo-controlled trial. The Lancet Infectious Diseases
    CrossRef

  2. 2

    Alexander M Aiken, Neema Mturi, Patricia Njuguna, Shebe Mohammed, James A Berkley, Isaiah Mwangi, Salim Mwarumba, Barnes S Kitsao, Brett S Lowe, Susan C Morpeth, Andrew J Hall, Iqbal Khandawalla, J Anthony G Scott. (2011) Risk and causes of paediatric hospital-acquired bacteraemia in Kilifi District Hospital, Kenya: a prospective cohort study. The Lancet 378:9808, 2021-2027
    CrossRef

  3. 3

    Sant-Rayn Pasricha. (2011) Should we screen for iron deficiency anaemia? A review of the evidence and recent recommendations. Pathology1
    CrossRef

  4. 4

    Michael B. van Hensbroek, Femkje Jonker, Imelda Bates. (2011) Severe acquired anaemia in Africa: new concepts. British Journal of Haematology 154:6, 690-695
    CrossRef

  5. 5

    Scott Dryden-Peterson, Roger L Shapiro, Michael D Hughes, Kathleen Powis, Anthony Ogwu, Claire Moffat, Sikhulile Moyo, Joseph Makhema, Max Essex, Shahin Lockman. (2011) Increased Risk of Severe Infant Anemia After Exposure to Maternal HAART, Botswana. JAIDS Journal of Acquired Immune Deficiency Syndromes 56:5, 428-436
    CrossRef

  6. 6

    P. E. Thuma, J. van Dijk, R. Bucala, Z. Debebe, S. Nekhai, T. Kuddo, M. Nouraie, G. Weiss, V. R. Gordeuk. (2011) Distinct Clinical and Immunologic Profiles in Severe Malarial Anemia and Cerebral Malaria in Zambia. Journal of Infectious Diseases 203:2, 211-219
    CrossRef

  7. 7

    Lucy A McNamara, Kathleen L Collins. (2011) Hematopoietic stem/precursor cells as HIV reservoirs. Current Opinion in HIV and AIDS 6:1, 43-48
    CrossRef

  8. 8

    Job CJ Calis, Kamija S Phiri, Raymond JWM Vet, Rob J de Haan, Francis Munthali, Robert J Kraaijenhagen, Paul JM Hulshof, Malcolm E Molyneux, Bernard J Brabin, Michaël Boele van Hensbroek, Imelda Bates. (2010) Erythropoiesis in HIV-infected and uninfected Malawian children with severe anemia. AIDS 24:18, 2883-2887
    CrossRef

  9. 9

    Peter J. Hotez, Jeffrey M. Bethony, David J. Diemert, Mark Pearson, Alex Loukas. (2010) Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nature Reviews Microbiology 8:11, 814-826
    CrossRef

  10. 10

    Imelda Bates, Ivy Ekem. 2010. Haematological Aspects of Tropical Diseases. , 956-970.
    CrossRef

  11. 11

    Stephen M Graham. (2010) Nontyphoidal salmonellosis in Africa. Current Opinion in Infectious Diseases 23:5, 409-414
    CrossRef

  12. 12

    Muh-Yong Yen, Yun-Ching Lu, Pi-Hsiang Huang, Chen-Ming Chen, Yee-Chun Chen, Yusen E. Lin. (2010) Quantitative evaluation of infection control models in the prevention of nosocomial transmission of SARS virus to healthcare workers: Implication to nosocomial viral infection control for healthcare workers. Scandinavian Journal of Infectious Diseases 42:6-7, 510-515
    CrossRef

  13. 13

    B. Cheema, E. M. Molyneux, J. C. Emmanuel, B. M'baya, M. Esan, H. Kamwendo, L. Kalilani-Phiri, M. Boele van Hensbroek. (2010) Development and evaluation of a new paediatric blood transfusion protocol for Africa. Transfusion Medicine 20:3, 140-151
    CrossRef

  14. 14

    Enrico M. Novelli, James B. Hittner, Gregory C. Davenport, Collins Ouma, Tom Were, Stephen Obaro, Sandra Kaplan, John M. Ong’echa, Douglas J. Perkins. (2010) Clinical predictors of severe malarial anaemia in a holoendemic Plasmodium falciparum transmission area. British Journal of Haematology 149:5, 711-721
    CrossRef

  15. 15

    Gregory C. Davenport, Collins Ouma, James B. Hittner, Tom Were, Yamo Ouma, John M. Ong'echa, Douglas J. Perkins. (2010) Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1. American Journal of Hematology 85:4, 227-233
    CrossRef

  16. 16

    Limangeni Mankhambo, Ajib Phiri, MacPherson Mallewa, Malcolm Molyneux. (2010) Management of severe malaria. Therapy 7:1, 27-38
    CrossRef

  17. 17

    Trijn Israëls, Eric Borgstein, Monica Jamali, Jan de Kraker, Huib N. Caron, Elizabeth M. Molyneux. (2009) Acute malnutrition is common in Malawian patients with a Wilms tumour: A role for peanut butter. Pediatric Blood & Cancer 53:7, 1221-1226
    CrossRef

  18. 18

    Incio Mandomando, Eusbio Macete, Betuel Sigaque, Luis Morais, Lloren Quint, Jahit Sacarlal, Mateu Espasa, Xavier Valls, Quique Bassat, Pedro Aide, Tacilta Nhampossa, Sonia Machevo, Joaquim Ruiz, Ariel Nhacolo, Clara Menndez, Karen L. Kotloff, Anna Roca, Myron M. Levine, Pedro L. Alonso. (2009) Invasive non-typhoidal Salmonella in Mozambican children. Tropical Medicine & International Health 14:12, 1467-1474
    CrossRef

  19. 19

    Oliver Hassall, Kathryn Maitland, Lewa Pole, Salim Mwarumba, Douglas Denje, Kongo Wambua, Brett Lowe, Christopher Parry, Kishor Mandaliya, Imelda Bates. (2009) TRANSFUSION COMPLICATIONS: Bacterial contamination of pediatric whole blood transfusions in a Kenyan hospital. Transfusion 49:12, 2594-2598
    CrossRef

  20. 20

    M. van Loon, D. G. Postels, G. T. Heikens, E. Molyneux. (2009) Severe pernicious anaemia in an 8-year-old African girl. Annals of Tropical Paediatrics: International Child Health 29:3, 231-234
    CrossRef

  21. 21

    W. P. O’MEARA, T. LANG. (2009) Malaria vaccine trial endpoints - bridging the gaps between trial design, public health and the next generation of vaccines. Parasite Immunology 31:9, 574-581
    CrossRef

  22. 22

    Nicholas M. Anstey, Bruce Russell, Tsin W. Yeo, Ric N. Price. (2009) The pathophysiology of vivax malaria. Trends in Parasitology 25:5, 220-227
    CrossRef

  23. 23

    Pierre A Buffet, Innocent Safeukui, Geneviève Milon, Odile Mercereau-Puijalon, Peter H David. (2009) Retention of erythrocytes in the spleen: a double-edged process in human malaria. Current Opinion in Hematology 16:3, 157-164
    CrossRef

  24. 24

    Somphou Sayasone, Smarn Tesana, Jürg Utzinger, Christoph Hatz, Kongsap Akkhavong, Peter Odermatt. (2009) Rare human infection with the trematode Echinochasmus japonicus in Lao PDR. Parasitology International 58:1, 106-109
    CrossRef

  25. 25

    K. Haldar, N. Mohandas. (2009) Malaria, erythrocytic infection, and anemia. Hematology 2009:1, 87-93
    CrossRef

  26. 26

    Danny A. Milner, Jacqui Montgomery, Karl B. Seydel, Stephen J. Rogerson. (2008) Severe malaria in children and pregnancy: an update and perspective. Trends in Parasitology 24:12, 590-595
    CrossRef

  27. 27

    Benedicta Baffoah Obeng, Franca Hartgers, Daniel Boakye, Maria Yazdanbakhsh. (2008) Out of Africa: what can be learned from the studies of allergic disorders in Africa and Africans?. Current Opinion in Allergy and Clinical Immunology 8:5, 391-397
    CrossRef

  28. 28

    KAMIJA S. PHIRI. (2008) Approaches to treating chronic anemia in developing countries. Transfusion Alternatives in Transfusion Medicine 10:2, 75-81
    CrossRef

  29. 29

    (2008) Severe Anemia in Malawian Children. New England Journal of Medicine 358:21, 2290-2291
    Full Text

Letters